Literature DB >> 9806326

Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.

S Aczél1, B Kurka, S Hering.   

Abstract

1. The action of mibefradil was studied on wild type class A calcium (Ca2+) channels and various class A/L-type channel chimaeras expressed in Xenopus oocytes. The mechanism of Ca2+ channel block by mibefradil was evaluated with two microelectrode voltage clamp. 2. Resting-state dependent block (or initial block) of barium currents (IBa) through class A Ca2+ channels was concentration dependent with an IC50 value of 208+/-23 microM. 3. Mibefradil (50 microM) did not significantly affect the midpoint voltage of the steady-state inactivation curve suggesting that inactivation does not promote Ca2+ channel block. Chimaeric class A/L-type Ca2+ channels inactivating with faster or slower kinetics than wild type class A channels were equally well inhibited by mibefradil as wild type class A channels. 4. Frequent Ca2+ channel activation facilitated IBa inhibition by mibefradil (use-dependent block). Recovery from use-dependent block was voltage-dependent, being slower at depolarized membrane potentials (tau = 75+/-15 s at -70 mV, (n=6) vs tau = 20+/-2 s at -100 mV, (n=6), P<0.05). 5. We suggest that use-dependent block of class A Ca2+ channels by mibefradil occurs because of slow recovery from open channel block (SROB) and not because of drug binding to inactivated channels. 6. Voltage-dependent slow recovery from open state-dependent block provides a molecular basis for understanding the cardiovascular profile of mibefradil such as selectivity for vasculature and relative lack of negative inotropic effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806326      PMCID: PMC1565645          DOI: 10.1038/sj.bjp.0702092

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

Review 1.  Molecular determinants of inactivation in voltage-gated Ca2+ channels.

Authors:  S Hering; S Berjukow; S Sokolov; R Marksteiner; R G Weiss; R Kraus; E N Timin
Journal:  J Physiol       Date:  2000-10-15       Impact factor: 5.182

2.  Inactivation determinant in the I-II loop of the Ca2+ channel alpha1-subunit and beta-subunit interaction affect sensitivity for the phenylalkylamine (-)gallopamil.

Authors:  S Sokolov; R G Weiss; B Kurka; F Gapp; S Hering
Journal:  J Physiol       Date:  1999-09-01       Impact factor: 5.182

3.  High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.

Authors:  P Eller; S Berjukov; S Wanner; I Huber; S Hering; H G Knaus; G Toth; S D Kimball; J Striessnig
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.

Authors:  A Farkas; A Qureshi; M J Curtis
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Pentobarbital inhibition of human recombinant alpha1A P/Q-type voltage-gated calcium channels involves slow, open channel block.

Authors:  A Schober; E Sokolova; K J Gingrich
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

6.  Voltage-gated calcium channel antagonists and traumatic brain injury.

Authors:  Gene Gurkoff; Kiarash Shahlaie; Bruce Lyeth; Robert Berman
Journal:  Pharmaceuticals (Basel)       Date:  2013-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.